Literature DB >> 6753317

Clinical and serological evidence of bovine babesiosis and anaplasmosis in St. Lucia.

R T Knowles, M Montrose, T M Craig, G G Wagner, R F Long.   

Abstract

One hundred fifty-nine Holstein calves were imported into St. Lucia from the U.S.A. An outbreak of babesiosis occurred 17 days post-arrival, and an outbreak of anaplasmosis occurred 5 months after importation. Sera obtained 3, 6, and 12 months post-importation revealed a high prevalence of IFA titres to Babesia bovis and B. Bigemina 3 months after arrival and an increase in titres to Anaplasma marginale 6 months after arrival. Sera obtained from native cattle from several places on the island indicated infection rates of 80, 65 and 64% with A. marginale, B. bigemina and B. bovis, respectively. The rapid card test only indicated a 25% prevalence of infection of native cattle by A. marginale. This low prevalence was probably due to deterioration of serological activity during shipment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753317     DOI: 10.1016/0304-4017(82)90081-4

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Bovine Babesia bigemina seroreactors in Jamaica.

Authors:  B McGinnis; G Grant; M Hugh-Jones; G Wagner
Journal:  Trop Anim Health Prod       Date:  1989-11       Impact factor: 1.559

2.  Seroprevalence of anaplasmosis and babesiosis in livestock on St Lucia, 1983.

Authors:  M E Hugh-Jones; K Scotland; L M Applewhaite; F M Alexander
Journal:  Trop Anim Health Prod       Date:  1988-08       Impact factor: 1.559

3.  Concurrent infections with vector-borne pathogens associated with fatal hemolytic anemia in a cattle herd in Switzerland.

Authors:  Regina Hofmann-Lehmann; Marina L Meli; Ute M Dreher; Enikö Gönczi; Peter Deplazes; Ueli Braun; Monika Engels; Jörg Schüpbach; Kaspar Jörger; Rudolf Thoma; Christian Griot; Katharina D C Stärk; Barbara Willi; Joseph Schmidt; Katherine M Kocan; Hans Lutz
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.